Filing
Spy
Filing
Spy
Home
About
KRTX — Karuna Therapeutics Inc - FilingSpy
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
3 holders
Ownership
Activity
Fundamentals
2022 Q1
8 of 14 quarters
Total Value
$156.46M
Total Shares
1.23M
Net Share Change
+109.8K
Activity
2 buying
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$123.54M
974.3K
0.5%
ADD
+110.7K
(+12.8%)
Viking Global Investors
$123.54M
974.3K shares
ADD
+110.7K
(+12.8%)
Miller Value Partners
$30.66M
241.8K
1.0%
ADD
+525
(+0.2%)
Miller Value Partners
$30.66M
241.8K shares
ADD
+525
(+0.2%)
Patient Capital Management
$2.26M
17.8K
0.8%
TRIM
-1.4K
(-7.3%)
Patient Capital Management
$2.26M
17.8K shares
TRIM
-1.4K
(-7.3%)